Affiliation:
1. Pfizer U.S. Regulatory Policy and Global Intelligence; Groton Connecticut USA
Subject
Pharmacology (medical),Pharmacology
Reference5 articles.
1. PMDA's challenge to accelerate clinical development and review of new drugs in Japan;Ichimaru;Clin. Pharmacol. Ther.,2010
2. Thomson Reuters Cortellis [Internet]. London, PA: Thomson Reuters http://thomsonreuters.com/cortellis-competitive-intelligence/
3. Relationship between drug lag and factors associated with clinical trials in Japan;Ohwaki;J. Clin. Pharmacol. Ther.,2014
4. Significant differences in drug lag in clinical development among various strategies used for regulatory submissions in Japan;Ueno;Clin. Pharmacol. Ther.,2014
5. Yamori , T. Science based initiatives of PMDA 2015
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献